News

Due to challenges in export sales in the regulated markets and a large base effect in the home formulations sector, the Indian pharmaceutical industry is anticipated to achieve moderate revenue growth of 7-9% in the current fiscal. Because of ongoing...

The NHS has now laid out plans for the next stage of the COVID-19 vaccination effort, the biggest and most rapid vaccine drive in the history of the health service, in response to the updated guidelines outlined by the...

Priority consideration has been given to AstraZeneca's supplemental new drug application for Lynparza (olaparib) when used in conjunction with abiraterone, prednisone, or prednisolone to treat elderly patients with advanced castration-resistant prostate cancer (mCRPC). AstraZeneca and MSD, also known as Merck...

It’s not surprising that turmeric has become one of the most common pantry staples and popular supplements. After all, not only does the spice add an incredible flavor to specific dishes, but it also possesses properties that can potentially...

Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was shown in a preclinical trial to have a neuroprotective impact on Alzheimer's disease, according to Genuv Inc. of South Korea, which has announced the...

It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with MDD diagnoses and the unmet demand. In light of this, the time is right for the...

Flu season is just around the horizon as the summer draws to a close and fall looms. Influenza still poses a threat, and leading vaccine developers are preparing to help fight it, even if the majority of the population...